Good Housekeeping, America’s iconic guide, highlighted Caregiver Action Network in “What I Learned When I Became My Parents’ Caregiver” published July 26, 2022.

Washington, DC (July 7, 2022) – The Caregiver Action Network (CAN) issued the following statement urging the U.S. Senate to rethink the drug pricing reform package:

“We strongly oppose lawmakers’ new reconciliation language as it would double down on failed prescription drug pricing proposals and uses the Medicare program as a pay-for to address their government mismanagement. Time and time again, mature Americans have warned price control policies would cause massive cuts to drug innovation, leading to fewer treatment options and longer wait times for care.

On June 17, 2022, Caregiver Action Network CEO, John Schall, testified in front of the FDA’s Psychopharmacologic Drugs Advisory Committee in support of approving Acadia Pharmaceuticals Inc.’s supplemental new drug application for NUPLAZID to treat the hallucinations and delusions associated with Alzheimer’s Disease psychosis. If approved, the drug would be the first therapy for the treatment of these behaviors associated with Alzheimer’s-related psychosis. 

CAN Opposes CMS’ Decision Regarding Monoclonal Antibodies Directed Against Amyloid for Treatment of Alzheimer’s Disease